Logo image of CAMT

CAMTEK LTD (CAMT) Stock Fundamental Analysis

NASDAQ:CAMT - IL0010952641 - Common Stock

89.22 USD
+2.32 (+2.67%)
Last: 8/28/2025, 11:59:55 AM
Fundamental Rating

6

Overall CAMT gets a fundamental rating of 6 out of 10. We evaluated CAMT against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. CAMT has an excellent profitability rating, but there are some minor concerns on its financial health. CAMT is valued quite expensively, but it does show have an excellent growth rating. With these ratings, CAMT could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

CAMT had positive earnings in the past year.
CAMT had positive earnings in each of the past 5 years.
CAMT had a positive operating cash flow in each of the past 5 years.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

The Return On Assets of CAMT (13.72%) is better than 86.36% of its industry peers.
Looking at the Return On Equity, with a value of 21.36%, CAMT belongs to the top of the industry, outperforming 87.27% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 13.47%, CAMT belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CAMT is in line with the industry average of 10.98%.
The 3 year average ROIC (11.43%) for CAMT is below the current ROIC(13.47%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.72%
ROE 21.36%
ROIC 13.47%
ROA(3y)11.71%
ROA(5y)10.6%
ROE(3y)19.67%
ROE(5y)17.82%
ROIC(3y)11.43%
ROIC(5y)11.2%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

CAMT has a Profit Margin of 28.38%. This is amongst the best in the industry. CAMT outperforms 88.18% of its industry peers.
CAMT's Profit Margin has improved in the last couple of years.
CAMT has a better Operating Margin (26.86%) than 86.36% of its industry peers.
CAMT's Operating Margin has improved in the last couple of years.
The Gross Margin of CAMT (50.46%) is better than 62.73% of its industry peers.
CAMT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.86%
PM (TTM) 28.38%
GM 50.46%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.46%
PM growth 5Y11.08%
GM growth 3Y-0.69%
GM growth 5Y0.63%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

5

2. Health

2.1 Basic Checks

CAMT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CAMT has been increased compared to 1 year ago.
CAMT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CAMT has an improved debt to assets ratio.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

CAMT has an Altman-Z score of 9.04. This indicates that CAMT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CAMT (9.04) is better than 75.45% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that CAMT is not too dependend on debt financing.
The Debt to Equity ratio of CAMT (0.32) is worse than 64.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 9.04
ROIC/WACC1.15
WACC11.69%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 5.41 indicates that CAMT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.41, CAMT is in the better half of the industry, outperforming 79.09% of the companies in the same industry.
A Quick Ratio of 4.38 indicates that CAMT has no problem at all paying its short term obligations.
CAMT has a Quick ratio of 4.38. This is in the better half of the industry: CAMT outperforms 77.27% of its industry peers.
Industry RankSector Rank
Current Ratio 5.41
Quick Ratio 4.38
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

CAMT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.80%, which is quite impressive.
CAMT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 34.86% yearly.
Looking at the last year, CAMT shows a very strong growth in Revenue. The Revenue has grown by 27.82%.
CAMT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.20% yearly.
EPS 1Y (TTM)30.8%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%19.7%
Revenue 1Y (TTM)27.82%
Revenue growth 3Y16.74%
Revenue growth 5Y26.2%
Sales Q2Q%20.2%

3.2 Future

Based on estimates for the next years, CAMT will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.41% on average per year.
Based on estimates for the next years, CAMT will show a quite strong growth in Revenue. The Revenue will grow by 15.97% on average per year.
EPS Next Y15.63%
EPS Next 2Y12.7%
EPS Next 3Y12.44%
EPS Next 5Y16.41%
Revenue Next Year15.5%
Revenue Next 2Y11.92%
Revenue Next 3Y11.79%
Revenue Next 5Y15.97%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

CAMT is valuated quite expensively with a Price/Earnings ratio of 28.78.
Compared to the rest of the industry, the Price/Earnings ratio of CAMT indicates a somewhat cheap valuation: CAMT is cheaper than 68.18% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CAMT to the average of the S&P500 Index (27.14), we can say CAMT is valued inline with the index average.
The Price/Forward Earnings ratio is 25.00, which indicates a rather expensive current valuation of CAMT.
65.45% of the companies in the same industry are more expensive than CAMT, based on the Price/Forward Earnings ratio.
CAMT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.80.
Industry RankSector Rank
PE 28.78
Fwd PE 25
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CAMT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 30.3
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CAMT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CAMT's earnings are expected to grow with 12.44% in the coming years.
PEG (NY)1.84
PEG (5Y)0.83
EPS Next 2Y12.7%
EPS Next 3Y12.44%

More info and screens

0

5. Dividend

5.1 Amount

CAMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAMTEK LTD

NASDAQ:CAMT (8/28/2025, 11:59:55 AM)

89.22

+2.32 (+2.67%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-10 2025-11-10/bmo
Inst Owners53.03%
Inst Owner Change-2.74%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap4.08B
Analysts85
Price Target99.25 (11.24%)
Short Float %13.23%
Short Ratio8.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.33
Dividend Growth(5Y)56.87%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.87%
Min EPS beat(2)-2.25%
Max EPS beat(2)0.51%
EPS beat(4)3
Avg EPS beat(4)1.36%
Min EPS beat(4)-2.25%
Max EPS beat(4)6.06%
EPS beat(8)7
Avg EPS beat(8)2.75%
EPS beat(12)10
Avg EPS beat(12)2.39%
EPS beat(16)12
Avg EPS beat(16)2.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-2.27%
Max Revenue beat(2)-0.59%
Revenue beat(4)1
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.3%
Revenue beat(12)2
Avg Revenue beat(12)-0.68%
Revenue beat(16)3
Avg Revenue beat(16)-0.74%
PT rev (1m)9.33%
PT rev (3m)0.66%
EPS NQ rev (1m)-0.58%
EPS NQ rev (3m)-1.5%
EPS NY rev (1m)-0.47%
EPS NY rev (3m)-0.85%
Revenue NQ rev (1m)0.74%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0.89%
Revenue NY rev (3m)-0.33%
Valuation
Industry RankSector Rank
PE 28.78
Fwd PE 25
P/S 8.65
P/FCF N/A
P/OCF N/A
P/B 6.5
P/tB 7.54
EV/EBITDA 30.3
EPS(TTM)3.1
EY3.47%
EPS(NY)3.57
Fwd EY4%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.31
BVpS13.72
TBVpS11.84
PEG (NY)1.84
PEG (5Y)0.83
Profitability
Industry RankSector Rank
ROA 13.72%
ROE 21.36%
ROCE 14.98%
ROIC 13.47%
ROICexc 13.47%
ROICexgc 14.99%
OM 26.86%
PM (TTM) 28.38%
GM 50.46%
FCFM N/A
ROA(3y)11.71%
ROA(5y)10.6%
ROE(3y)19.67%
ROE(5y)17.82%
ROIC(3y)11.43%
ROIC(5y)11.2%
ROICexc(3y)23.25%
ROICexc(5y)34.93%
ROICexgc(3y)26.06%
ROICexgc(5y)36.79%
ROCE(3y)12.71%
ROCE(5y)12.46%
ROICexcg growth 3Y-39.43%
ROICexcg growth 5Y-18.22%
ROICexc growth 3Y-41.68%
ROICexc growth 5Y-20%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.46%
PM growth 5Y11.08%
GM growth 3Y-0.69%
GM growth 5Y0.63%
F-ScoreN/A
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 1.44
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.41
Quick Ratio 4.38
Altman-Z 9.04
F-ScoreN/A
WACC11.69%
ROIC/WACC1.15
Cap/Depr(3y)145.49%
Cap/Depr(5y)140.52%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.15%
Profit Quality(3y)82.13%
Profit Quality(5y)89.36%
High Growth Momentum
Growth
EPS 1Y (TTM)30.8%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%19.7%
EPS Next Y15.63%
EPS Next 2Y12.7%
EPS Next 3Y12.44%
EPS Next 5Y16.41%
Revenue 1Y (TTM)27.82%
Revenue growth 3Y16.74%
Revenue growth 5Y26.2%
Sales Q2Q%20.2%
Revenue Next Year15.5%
Revenue Next 2Y11.92%
Revenue Next 3Y11.79%
Revenue Next 5Y15.97%
EBIT growth 1Y48.56%
EBIT growth 3Y16.58%
EBIT growth 5Y38.59%
EBIT Next Year23.07%
EBIT Next 3Y17.33%
EBIT Next 5Y19.53%
FCF growth 1Y57.63%
FCF growth 3Y25.41%
FCF growth 5Y36.93%
OCF growth 1Y53.8%
OCF growth 3Y26.02%
OCF growth 5Y37.72%